An Overview of Tumor Biology

References

• Duesberg P H. Cancer genes: Rare recombinants instead of activated oncogenes (a review). Proc Natl Acad Sci (USA) 1987; 84: 2117–2124
   PubMed Web of Science ®Google Scholar
• Bishop J M. The molecular genetics of cancer. Science 1987; 235: 303–311
   Web of Science ®Google Scholar
• Marshall C J. Meeting report: Oncogenes and growth control 1987. Cell 1987; 49: 723–725
   Web of Science ®Google Scholar
• Forrester K, Almoguera C, Han K, et al. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987; 327: 298–303
   PubMed Web of Science ®Google Scholar
• Bos J L, Fearon E R, Hamilton S R, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987; 327: 293–297
   PubMed Web of Science ®Google Scholar
• Der C J, Pan B T, Cooper G M. RasH mutants deficient in GTP binding. Mol Cell Biol 1986; 6: 3291–3294
   PubMed Web of Science ®Google Scholar
• Der C J, Finkel T, Cooper G M. Biological and biochemical properties of human rasH genes mutated at codon 61. Cell 1986; 44: 167–176
   PubMed Web of Science ®Google Scholar
• Trahey M, Milley R J, Cole G E, et al. Biochemical properties of the human N-ras p21 protein. Mol Cell Biol 1987; 7: 541–544
   PubMed Web of Science ®Google Scholar
• Willumsen B M, Papageorge A G, Kung H F, et al. Mutational analysis of a ras catalytic domain. Mol Cell Biol 1986; 6: 2646–2654
   PubMed Web of Science ®Google Scholar
• Parries G, Hoebel R, Racker E. Opposing effects of a ras oncogene on growth factor-stimulated phosphoinositide hydrolysis: Desen-sitization to platelet-derived growth factor and enhanced sensitivity to bradykinin. Proc Natl Acad Sci (USA) 1987; 84: 2648–2652
   PubMed Web of Science ®Google Scholar
• Wolfman A, Macara I G. Elevated levels of diacylglycerol and decreased phorbol ester sensitivity in ras-transformed fibroblasts. Nature 1987; 325: 359–361
   PubMed Web of Science ®Google Scholar
• Wakelam M J, Davies S A, Houslay M D, et al. Normal p21ras couples bombesin and other growth factor receptors to inositol phosphate production. Nature 1986; 323: 173–176
   PubMed Web of Science ®Google Scholar
• Bar-Sagi D, Feramisco J R. Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. Science 1986; 233: 1061–1068
   PubMed Web of Science ®Google Scholar
• Riedel H, Schlessinger J., Ullrich A. A chimeric, ligand-binding v-erbB/EGF receptor retains transforming potential. Science 1987; 236: 197–200
   PubMed Web of Science ®Google Scholar
• Sacca R, Stanley E R, Sherr C J, et al. Specific-binding of the mononuclear phagocyte colony-stimulating factor CSF-1 to the product of the v-fms oncogene. Proc Natl Acad Sci (USA) 1986; 83: 3331–3335
   PubMed Web of Science ®Google Scholar
• Sherr C J, Rettenmier C W. The fms gene and the CSF-1 receptor. Cancer Surv 1986; 5: 223–232
   Google Scholar
• Roussel M F, Dull T J, Rettenmier C W, et al. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor). Nature 1987; 325: 549–552
   PubMed Web of Science ®Google Scholar
• Wheeler E F, Askew D, May S, et al. The v-fms oncogene induces factor-independent growth and transformation of the interleukin-3-dependent myeloid cell line FDC-P1. Mol Cell Biol 1987; 7: 1673–1680
   PubMed Web of Science ®Google Scholar
• Wheeler E F, Rettenmier C W, Look A T, et al. The v-fms oncogene induces factor-independence and tumorigenicity in CSF-1 dependent macrophage cell line. Nature 1986; 324: 377–379
   PubMed Web of Science ®Google Scholar
• Browning P J, Bunn H F, Cline A, et al. “Replacement” of COOH-terminal truncation of v-fms with c-fms sequences markedly reduces transformation potential. Proc Natl Acad Sci (USA) 1986; 83: 7800–7804
   PubMed Web of Science ®Google Scholar
• Cartwright C A, Eckhart W, Simon S, et al. Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain. Cell 1987; 49: 83–91
   PubMed Web of Science ®Google Scholar
• Piwnica-Worms H, Saunders K B, Roberts T M, et al. Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-scr. Cell 1987; 49: 75–82
   PubMed Web of Science ®Google Scholar
• Kmiecik T E, Shalloway D. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell 1987; 49: 65–73
   PubMed Web of Science ®Google Scholar
• Hunter T. A tail of two src's: Mutatis mutandis. Cell 1987; 49: 1–4
   PubMed Web of Science ®Google Scholar
• Bolen J B, Veillette A, Schwartz A M, et al. Activation of pp60m protein kinase activity in human colon carcinoma. Proc Natl Acad Sci (USA) 1987; 84: 2251–2255
   PubMed Web of Science ®Google Scholar
• Friend S H, Bernards R, Rogelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986; 323: 643–646
   PubMed Web of Science ®Google Scholar
• Weissman B E, Saxon P J, Pasquale S R, et al. Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression. Science 1987; 236: 175–180
   PubMed Web of Science ®Google Scholar
• Geiser A G, Der C L, Marshall C J, et al. Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells. Proc Natl Acad Sci (USA) 1986; 83: 5209–5213
   PubMed Web of Science ®Google Scholar
• Koi M, Barrett J C. Loss of tumor-suppressive function during chemically induced neoplastic progression of Syrian hamster embryo cells. Proc Natl Acad Sci (USA) 1986; 83: 5992–5996
   PubMed Web of Science ®Google Scholar
• Kurzrock R, Shtalrid M, Romero P, et al. A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukemia. Nature 1987; 325: 631–635
   PubMed Web of Science ®Google Scholar
• Chan L C, Karhi K K, Rayter S I, et al. A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia. Nature 1987; 325: 635–637
   PubMed Web of Science ®Google Scholar
• Ishikawa F, Takaku F, Nagao M, et al. Rat c-raf oncogene activation by a rearrangement that produces a fused protein. Mol Cell Biol 1987; 7: 1226–1232
   PubMed Web of Science ®Google Scholar
• Park M, Dean M, Cooper C S, et al. Mechanism of met oncogene activation. Cell 1986; 45: 895–904
   PubMed Web of Science ®Google Scholar
• Takahashi M, Cooper G M. ret Transforming gene encodes a fusion protein homologous to tyrosine kinases. Mol Cell Biol 1987; 7: 1378–1385
   PubMed Web of Science ®Google Scholar
• Sap J, Munoz A, Damm K, et al. The c-erbA protein is a high-affinity receptor for thyroid hormone. Nature 1986; 324: 635–646
   PubMed Web of Science ®Google Scholar
• Green S, Chambon P. A superfamily of potentially oncogenic hormone receptors. Nature 1986; 324: 615–617
   PubMed Web of Science ®Google Scholar
• Bargmann C I, Hung M C, Weinberg R A. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 1986; 45: 649–657
   PubMed Web of Science ®Google Scholar
• Young D, Waitches G, Birchmeier C, et al. Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains. Cell 1986; 45: 711–719
   PubMed Web of Science ®Google Scholar
• Chabre M. The G protein connection: Is it in the membrane or the cytoplasm?. TIBS 1987; 12: 213–215
   Web of Science ®Google Scholar
• Cockcroft S. Phosphoinositide phosphodiesterase: Regulation by a novel guanine nucleotide binding protein. Gp. TIBS 1987; 12: 75–78
   Web of Science ®Google Scholar
• Bourne H R. One molecular mechanism can transduce diverse signals. Nature 1986; 321: 814–816
   PubMed Web of Science ®Google Scholar
• Pennington S R. G proteins and diabetes. Nature 1987; 327: 188–189
   PubMed Web of Science ®Google Scholar
• Marx J L. Polyphosphoinositide research updated. Science 1987; 235: 974–976
   PubMed Web of Science ®Google Scholar
• Fleischman L F, Chahwala S B, Cantley L. Ras-transformed cells: Altered levels of phosphatidylinositol-4,5-biphosphate and catabolites. Science 1986; 231: 407–410
   PubMed Web of Science ®Google Scholar
• Croce C M. Chromosome translocations and human cancer. Cancer Res 1986; 46: 6019–6023
   PubMed Web of Science ®Google Scholar
• Croce C M. Role of chromosome translocations in human neoplasia. Cell 1987; 49: 155–156
   PubMed Web of Science ®Google Scholar
• Haluska F G, Finver S, Tsujimoto Y, et al. The t(8:14) chromosomal translocation occurring in B-cell malignancies results from mistakes in V-D-J joining. Nature 1986; 324: 158–160
   PubMed Web of Science ®Google Scholar
• Finger L R, Harvey R C, Moore R C, et al. A common mechanism of chromosomal translocation in T- and B-cell neoplasia. Science 1986; 234: 982–985
   PubMed Web of Science ®Google Scholar
• Murphy W, Sarid J, Taub R, et al. A translocated human c-myc oncogene is altered in a conserved coding sequence. Proc Natl Acad Sci (USA) 1986; 83: 2939–2943
   PubMed Web of Science ®Google Scholar
• Showe L C, Moore R C, Erikson J, et al. Myc oncogene involved in a t(8;22) chromosome translocation is not altered in its putative regulatory regions. Proc Natl Acad Sci (USA) 1987; 84: 2824–2828
   PubMed Web of Science ®Google Scholar
• Pelicci P G, Knowles D M, Magrath I, et al. Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc Natl Acad Sci (USA) 1986; 83: 2984–2988
   PubMed Web of Science ®Google Scholar
• Rosen N, Reynolds C P, Thiele C J, et al. Increased N-myc expression following progressive growth of human neuroblastoma. Cancer Res 1986; 46: 4139–4142
   PubMed Web of Science ®Google Scholar
• Slamon D J, Clark G M, Wong S G, et al. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235: 177–182
   PubMed Web of Science ®Google Scholar
• Wong A J, Ruppert J M, Eggleston J, et al. Gene amplification of c-myc and N-myc in small cell carcinoma of the lung. Science 1986; 233: 461–464
   PubMed Web of Science ®Google Scholar
• Winter E, Perucho M. Oncogene amplification during tumorigenesis of established rat fibroblasts reversibly transformed by activated human ras oncogenes. Mol Cell Biol 1986; 6: 2562–2570
   PubMed Web of Science ®Google Scholar
• George D L. Amplification of cellular proto-oncogenes in tumors and tumor cell lines. Cancer Surv 1984; 3: 497–513
   Google Scholar
• Bernards R, Dessain S K, Weinberg R A. N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastoma. Cell 1986; 47: 667–674
   PubMed Web of Science ®Google Scholar
• Ford M, Fried M. Large inverted duplications are associated with gene amplification. Cell 1986; 45: 425–430
   PubMed Web of Science ®Google Scholar
• Meinkoth J, Killary A M, Fournier R E, et al. Unstable and stable CAD gene amplification: Importance of flanking sequences and nuclear environment in gene amplification. Mol Cel Biol 1987; 7: 1415–1424
   PubMed Web of Science ®Google Scholar
• Readhead C, Popko B, Takahashi N, et al. Expression of a myelin basic protein gene in transgenic Shiverer mice: correction of the dysmyleinating phenotype. Cell 1987; 48: 703–712
   PubMed Web of Science ®Google Scholar
• Constantini F, Chada K, Magram J. Correction of murine B-thalassemia by gene transfer into the germ line. Science 1986; 233: 1192–1194
   PubMed Web of Science ®Google Scholar
• LeMeur M, Gerlinger P, Benoist C, et al. Correcting an immunoresponse deficiency by creating E alpha gene transgenic mice. Nature 1985; 316: 38–42
   PubMed Web of Science ®Google Scholar
• Yamamura K, Kikutoni H, Folson V, et al. Functional expression of a microinjected Ed alpha gene in C57BL/6 transgenic mice. Nature 1985; 316: 67–69
   PubMed Web of Science ®Google Scholar
• Ruther U, Garber C, Komitowski D, et al. Deregulated c-fos expression interferes with normal bone development in transgenic mice. Nature 1987; 325: 412–416
   PubMed Web of Science ®Google Scholar
• Brinster R L, Chen H Y, Messing A, et al. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell 1984; 37: 367–379
   PubMed Web of Science ®Google Scholar
• Hanahan D. Heritable formation of pancreatic B-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 1985; 315: 115–122
   PubMed Web of Science ®Google Scholar
• Ornitz D M, Palmiter R D, Messing A, et al. Elastase 1 promoter directs expression of human growth hormone and SV40 T-antigen genes to pancreatic acinar cells in transgenic mice. Cold Spring Harbor Symp Quant Biol 1985; 50: 399–409
   PubMedGoogle Scholar
• Mahon K A, Chepelinsky A B, Khillan J S, et al. Oncogenesis of the lens in transgenic mice. Science 1987; 235: 1622–1628
   PubMed Web of Science ®Google Scholar
• Andres A C, Schonenberger C A, Groner B, et al. Ha-ras oncogene expression directed by a milk protein gene promoter: tissue specificity, hormonal regulation, and tumor induction in transgenic mice. Proc Natl Acad Sci (USA) 1987; 84: 1299–1303
   PubMed Web of Science ®Google Scholar
• Quaife C J, Pinkert C A, Ornitz D M, et al. Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice. Cell 1987; 48: 1023–1034
   PubMed Web of Science ®Google Scholar
• Adams J M, Harris A W, Langdon W Y, et al. c-Myc-induced lymphomagenesis in transgenic mice and the role of the pvt-1 locus in lymphoid neoplasia. Curr Topics Microbiol Immunol 1986; 132: 1–8
   PubMed Web of Science ®Google Scholar
• Langdon W Y, Harris A W, Cory S, et al. The c-myc oncogene perturbs B lymphocyte development in Eu-myc transgenic mice. Cell 1986; 47: 11–18
   PubMed Web of Science ®Google Scholar
• Alexander W S, Schrader J W, Adams J M. Expression of the c-myc oncogene under control of an immunoglobulin enhancer in Eu-myc transgenic mice. Mol Cel Biol 1987; 7: 1436–1444
   PubMed Web of Science ®Google Scholar
• Leder A, Pattengale P K, Kuo A, et al. Consequences of widespread deregulation of the c-myc gene in transgenic mice: Multiple neoplasms and normal development. Cell 1986; 45: 485–495
   PubMed Web of Science ®Google Scholar
• Sinn E, Muller W, Pattengale P, et al. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo. Cell 1987; 49: 465–475
   PubMed Web of Science ®Google Scholar
• Hanahan D. Oncogenesis in transgenic mice. Oncogenes and Growth Control, P Kahn, T Graf. Springer-Veriag, New York 1986; 349–363
   Google Scholar
• Klein G, Klein E. Conditioned tumorigenicity of activated oncogenes. Cancer Res 1986; 46: 3211–3224
   PubMed Web of Science ®Google Scholar
• Pardee A B. Molecules involved in proliferation of normal and cancer cells: Presidential address. Cancer Res 1987; 47: 1488–1491
   PubMed Web of Science ®Google Scholar
• Lee M G, Nurse P. Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2. Nature 1987; 327: 31–35
   PubMed Web of Science ®Google Scholar
• Wier M L, Scott R E. Regulation of the terminal event in cellular differentiation: Biological mechanisms of the loss of proliferative potential. J Cell Biol 1986; 102: 1955–1964
   PubMed Web of Science ®Google Scholar
• Sparks R L, Seibel-Ross E I, Wier M L, et al. Differentiation, dedifferentiation and transdifferentiation of BALB/c 3T3 T mesenchymal stem cells: Potential significance in metaplasia and neoplasia. Cancer Res 1986; 46: 5312–5319
   PubMed Web of Science ®Google Scholar
• Dmitrovsky E, Kuehl W M, Hollis G F, et al. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line. Nature 1986; 322: 748–750
   PubMed Web of Science ®Google Scholar
• Prochownik E V, Kukowska J. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation. Nature 1986; 322: 848–850
   PubMed Web of Science ®Google Scholar
• Resnitzky D, Yarden A, Zipori D, et al. Autocrine B-related interferon controls c-myc suppression and growth arrest during hematopoietic cell differentiation. Cell 1986; 46: 31–40
   PubMed Web of Science ®Google Scholar
• Olson E, Spizz G, Tainsky M A. The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation. Mol Cell Biol 1987; 7: 2104–2111
   PubMed Web of Science ®Google Scholar
• Leon J, Guerrero I, Pellicer A. Differential expression of the ras gene family in mice. Mol Cell Biol 1987; 7: 1535–1540
   PubMed Web of Science ®Google Scholar
• Chesa P G, Rettig W J, Melamed M R, et al. Expression of p21ras in normal and malignant human tissues: Lack of association with proliferation and malignancy. Proc Natl Acad Sci (USA) 1987; 84: 3234–3238
   PubMed Web of Science ®Google Scholar
• Reinach F C, MacLeod A R. Tissue-specific expression of the human tropomyosin gene involved in the generation of the trk oncogene. Nature 1986; 322: 648–650
   PubMed Web of Science ®Google Scholar
• Lynch S A, Brugge J S, Levine J M. Induction of altered c-src product during neural differentiation of embryonal carcinoma cells. Science 1986; 234: 873–876
   PubMed Web of Science ®Google Scholar
• Gee C E, Griffin J, Sastre L, et al. Differentiation of myeloid cells is accompanied by increased levels of pp60c-src protein kinase activity. Proc Natl Acad Sci (USA) 1986; 83: 5131–5135
   PubMed Web of Science ®Google Scholar
• Cooper G M, Goldman D S, Kiessling A A, et al. Oncogene expression in germ cells, In preparation
   Google Scholar
• Jacobovits A, Shackleford G M, Varmus H E, et al. Two proto-oncogenes implicated in mammary carcinogenesis, int-1 and int-2 are independently regulated during mouse development. Proc Natl Acad Sci (USA) 1986; 83: 7806–7810
   PubMed Web of Science ®Google Scholar
• Maniatis T, Goodbourn S, Fischer J A. Regulation of inducible and tissue-specific gene expression. Science 1987; 236: 1237–1244
   PubMed Web of Science ®Google Scholar
• McKnight S., Tjian R. Transcriptional selectivity of viral genes in mammalian cells. Cell 1986; 46: 795–805
   PubMed Web of Science ®Google Scholar
• Struhl K. Promoters, activator proteins, and the mechanism of transcriptional initiation in yeast. Cell 1987; 49: 295–297
   PubMed Web of Science ®Google Scholar
• Lee W, Haslinger A, Kariri M, et al. Activation of transcription by two factors that bind promotor and enhancer sequences of the human metallothionein gene and SV40. Nature 1987; 325: 368–370
   PubMed Web of Science ®Google Scholar
• Kadonaga J T, Tjian R. Affinity purification of sequence-specific DNA binding proteins. Proc Natl Acad Sci (USA) 1986; 83: 5889–5893
   PubMed Web of Science ®Google Scholar
• Briggs M R, Kadonaga J T, Bell S P, et al. Purification and biochemical characterization of the promoter-specific transcription factor, Spl. Science 1986; 234: 47–52
   PubMed Web of Science ®Google Scholar
• Jones K A, Kadonaga J T, Rosenfeld P J, et al. A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication. Cell 1987; 48: 79–89
   PubMed Web of Science ®Google Scholar
• Schleif R. Why should DNA loop?. Nature 1987; 327: 369–370
   PubMed Web of Science ®Google Scholar
• Echols H. Multiple DNA-protein interactions governing high precision DNA transactions. Science 1986; 233: 1050–1056
   PubMed Web of Science ®Google Scholar
• Holt J T, Venkat T, Moulton A D, et al. Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation. Proc Natl Acad Sci (USA) 1986; 83: 4794–4798
   PubMed Web of Science ®Google Scholar
• Nishikura K, Murray J M. Antisense RNA of proto-oncogene c-fos blocks renewed growth of quiescent 3T3 cells. Mol Cell Biol 1987; 7: 639–647
   PubMed Web of Science ®Google Scholar
• Studzinski G P, Brelvi Z S, Feldman S C, et al. Participation of c-myc protein in DNA synthesis of human cells. Science 1986; 234: 467–470
   PubMed Web of Science ®Google Scholar
• Bravo R, Neuberg M, Burckhardt J, et al. Involvement of common and cell type-specific pathways in c-fos gene control: Stable induction by cAMP in macrophages. Cell 1987; 48: 251–260
   PubMed Web of Science ®Google Scholar
• Prywes R, Roeder R G. Inducible binding of a factor to the c-fos enhancer. Cell 1986; 47: 777–784
   PubMed Web of Science ®Google Scholar
• Sassone-Corsi P, Verma I. Modulation of c-fos gene transcription by negative and positive cellular factors. Nature 1987; 326: 507–510
   PubMed Web of Science ®Google Scholar
• Gilman M Z, Wilson R N, Weinberg R A. Multiple protein binding sites in the 5′-flanking region regulate c-fos expression. Mol Cell Biol 1986; 6: 4305–4316
   PubMed Web of Science ®Google Scholar
• Treisman R. Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell 1986; 46: 567–574
   PubMed Web of Science ®Google Scholar
• Chung J, Sinn E, Reed R R, et al. Trans-acting elements modulate expression of the human c-myc gene in Burkitt lymphoma cells. Proc Natl Acad Sci (USA) 1986; 83: 7918–7922
   PubMed Web of Science ®Google Scholar
• Marcu K B. Regulation of the expression of the c-myc proto-oncogene. BioEssays 1986; 6: 28–32
   Web of Science ®Google Scholar
• Sheridan J D, Atkinson M M. Physiological roles of permeable junctions: Some possibilities. Ann Rev Physiol 1985; 47: 337–353
   PubMed Web of Science ®Google Scholar
• Loewenstein W R. The cell-to-cell channel of gap junctions. Cell 1987; 48: 725–726
   PubMed Web of Science ®Google Scholar
• Mehta P P, Bertram J S, Loewenstein W R. Growth inhibition of transformed cells correlates with their junctional communication with normal cells. Cell 1986; 44: 187–196
   PubMed Web of Science ®Google Scholar
• Azarnia R, Loewenstein W R. Polyomavirus middle T antigen down regulates junctional cell-to-cell communication. Mol Cell Biol 1987; 7: 946–950
   PubMed Web of Science ®Google Scholar
• Chang C C, Trosko J E, Kung H J, et al. Potential role of src gene product in inhibition of gap-junctional communication in NIH/3T3 cells. Proc Natl Acad Sci (USA) 1985; 82: 5360–5364
   PubMed Web of Science ®Google Scholar
• Maher P A, Pasquale E B, Wang J Y, et al. Phosphotyrosine-containing proteins are concentrated in focal adhesions and intracellular junctions in normal cells. Proc Natl Acad Sci (USA) 1985; 82: 6576–6580
   PubMed Web of Science ®Google Scholar
• Young J D, Cohn Z A, Gilula N B. Functional assembly of gap junction conductance in lipid bilayers: Demonstration that the major 27 kd protein forms the junctional channel. Cell 1987; 48: 733–743
   PubMed Web of Science ®Google Scholar
• Paul D L. Molecular cloning of cDNA for rat liver gap junction protein. J Cell Biol 1986; 103: 123–134
   PubMed Web of Science ®Google Scholar
• Kumar N M, Gilula N B. Cloning and characterization of human and rat liver cDNAs coding for a gap junction protein. J Cell Biol 1986; 103: 767–776
   PubMed Web of Science ®Google Scholar
• Marks P A, Sheffery M, Rifkind R A. Induction of transformed cells to terminal differentiation and the modulation of gene expression. Cancer Res 1987; 47: 659–666
   PubMed Web of Science ®Google Scholar
• Gerschenson M, Graves K, Carson S D, et al. Regulation of melanoma by embryonic skin. Proc Natl Acad Sci (USA) 1986; 83: 7307–7310
   PubMed Web of Science ®Google Scholar
• Newmark P. Oncogenes and cell growth. Nature 1987; 327: 101–102
   PubMed Web of Science ®Google Scholar
• Sachs L. Cell differentiation and bypassing of genetic defects in the suppression of malignancy. Cancer Res 1987; 47: 1981–1986
   PubMed Web of Science ®Google Scholar
• Olden K, Matsumoto K, White S, et al. Inhibition of B16-F10 melanoma experimental metastasis: Recent approaches (abstr. Q220). J Cell Biochem 1987; 11D(Suppl)110
   Google Scholar
• Furcht L T, McCarthy J B, Nordan-Skubitz A, et al. Role of laminin and fibronectin domains in the migration and in vivo metastasis of tumor cells (abstr.). International Congress, Cancer Metastasis, BolognaItaly, May, 13–151987, 33
   Google Scholar
• Sloane B F, Rozhin J, Lah T T, et al. Tumor cathepsin B and its endogenous inhibitor in metastasis (abstr). International Congress, Cancer Metastasis, BolognaItaly, May, 13–151987, 41
   Google Scholar
• Dennis J W, Laferte S, Waghorne C, et al. B1–6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 1986; 236: 582–585
   Web of Science ®Google Scholar
• Liteplo R G, Kerbel R S. Reduced levels of DNA 5-methylcytosine in metastatic variants of the human melanoma line MeWo. Cancer Res 1987; 47: 2264–2267
   PubMed Web of Science ®Google Scholar
• Jones P A, Chandler L A, Ghazi H, et al. DNA methylation patterns and tumor heterogeneity (abstr. Q006). J Cell Biochem 1987; 11D(Suppl)80
   Google Scholar
• Pulciani S, Santos E, Long L K, et al. ras Gene amplification and malignant transformation. Mol Cell Biol 1985; 5: 2836–2841
   PubMed Web of Science ®Google Scholar
• Bernstein S C, Weinberg R A. Expression of the metastatic phenotype in cells transfected with human metastatic tumor DNA. Proc Natl Acad Sci (USA) 1985; 82: 1726–1730
   PubMed Web of Science ®Google Scholar
• Bradley M D, Kraynak A R, Storer R D, et al. Experimental metastasis in nude mice of N1H 3T3 cells containing various ras genes. Proc Natl Acad Sci (USA) 1986; 83: 5277–5281
   PubMed Web of Science ®Google Scholar
• Egan S E, McClarty G A, Jarolim L, et al. Expression of H-ras correlates with metastatic potential: Evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells. Mol Cell Biol 1987; 7: 830–837
   PubMed Web of Science ®Google Scholar
• Egan S E, Jarolim L, Wright J A, et al. Direct regulation of the metastatic phenotype in established rodent fibroblasts by normal and activated H-ras (abstr. Q110). J Cell Biol 1987; 1ID(Suppl)97
   Google Scholar
• Muschel R J. RasH oncogenes and metastasis. J Cell Biochem (abstr. Q011). J Cell Biochem 1987; 11D(Suppl)83
   Google Scholar
• Pozzatti R, Muschel R, Wiliams J, et al. Primary rat embryo cells transformed by one or two oncogenes show different metastatic potentials. Science 1986; 232: 223–227
   PubMed Web of Science ®Google Scholar
• Kerbel R S, Waghorne C, Man M S, et al. Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate-mediated DN A transfection. Proc Natl Acad Sci (USA) 1987; 84: 1263–1267
   PubMed Web of Science ®Google Scholar